Product Description: Bexirestrant is an orally active ER-α degrader. Bexirestrant can be used for the research of antiestrogen, antineoplastic[1][2].
Applications: Cancer-programmed cell death
Formula: C29H26F3NO2
References: [1]Ranjan Kumar Pal, et al, Selective estrogen receptor degrader. WO2021014386 A1./[2]WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.
CAS Number: 2505067-70-7
Molecular Weight: 477.52
Compound Purity: 99.46
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Estrogen Receptor/ERR